Free Newsletter
Register for our Free Newsletters
Newsletter
Zones
Advanced Composites
LeftNav
Aerospace
LeftNav
Amorphous Metal Structures
LeftNav
Analysis and Simulation
LeftNav
Asbestos and Substitutes
LeftNav
Associations, Research Organisations and Universities
LeftNav
Automation Equipment
LeftNav
Automotive
LeftNav
Biomaterials
LeftNav
Building Materials
LeftNav
Bulk Handling and Storage
LeftNav
CFCs and Substitutes
LeftNav
Company
LeftNav
Components
LeftNav
Consultancy
LeftNav
View All
Other Carouselweb publications
Carousel Web
Defense File
New Materials
Pro Health Zone
Pro Manufacturing Zone
Pro Security Zone
Web Lec
Pro Engineering Zone
 
 
 
News

Advances in multiple sclerosis research to be presented at meeting hosted by Yale and veterans

Yale University : 01 April, 2003  (Company News)
Research aimed at finding new drug therapies for the paralysis, loss of vision, pain and other symptoms related to multiple sclerosis will be presented in a meeting on April 17 at the Veterans Administration Medical Center in West Haven.
Research aimed at finding new drug therapies for the paralysis, loss of vision, pain and other symptoms related to multiple sclerosis will be presented in a meeting on April 17 at the Veterans Administration Medical Center in West Haven.

The event will be hosted by the Paralyzed Veterans of America in association with the PVA/Eastern PVA Center for Neuroscience and Regeneration Research at Yale University. It is intended to coincide with PVA Awareness Week.

PVA Awareness Week seeks to increase public awareness of its mission to serve veterans with disabilities, especially those with spinal cord injuries and multiple sclerosis. The PVA is a congressionally chartered veterans service organization and a strong advocate for many issues related to individuals with disabilities, including research and education in the area of spinal cord disorders.

'This event provides an excellent opportunity for individuals with interest in multiple sclerosis to learn more about the cutting edge research on functional restoration through cell transplantation, neuropathic pain, neuroprotection and identification of therapeutic targets that will permit more effective treatment of symptoms such as paralysis, loss of vision, and pain in multiple sclerosis,' said Steven Waxman, M.D., chair of the Department of Neurology at Yale School of Medicine.

The PVA funded the construction of the PVA/EPVA Center at Yale in 1988 and continues to provide funds for research, equipment, training and education within the center.
Bookmark and Share
 
Home I Editor's Blog I News by Zone I News by Date I News by Category I Special Reports I Directory I Events I Advertise I Submit Your News I About Us I Guides
 
   © 2012 NewMaterials.com
Netgains Logo